| Members |
targetComponentId |
| Divalproex sodium 500mg m/r tablet |
Valproic acid only product in oral dose form |
| Divalproex sodium 500mg prolonged-release oral tablet |
Valproic acid only product in oral dose form |
| Diversional therapy |
Diversional therapy |
| Division Tenericutes |
Phylum Mycoplasmatota (organism) |
| Division of palmar aponeurosis for repair of Dupuytren contracture |
Division of palmar aponeurosis for correction of Dupuytren contracture (procedure) |
| Dobutamine 12.5mg/mL infusion concentrate 20mL vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dobutamine 50mg/mL infusion concentrate 5mL ampule |
Dobutamine (as dobutamine hydrochloride) 50 mg/mL solution for injection |
| Dobutamine hydrochloride 12.5mg/ml infusion concentrate 20ml vial |
Product containing precisely dobutamine (as dobutamine hydrochloride) 12.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Does not, dependent |
Does not |
| Dog allergy vaccine |
Dog allergy vaccine (product) |
| Doll's eye sign |
Doll's head reflex |
| Dolphin distemper virus |
Cetacean morbillivirus (organism) |
| Domain Archaea |
Domain Archaea |
| Domestic animal species, non-primate |
Class Mammalia (organism) |
| Domestic animals |
Class Mammalia (organism) |
| Domestic partner of subject |
Domestic partner (person) |
| Donepezil 10mg orally disintegrating tablet |
Product containing precisely donepezil hydrochloride 10 milligram/1 each conventional release orodispersible tablet (clinical drug) |
| Donepezil 1mg/mL oral solution |
Donepezil hydrochloride 1 mg/mL oral solution |
| Donepezil 5mg orally disintegrating tablet |
Donepezil hydrochloride 5 mg orodispersible tablet |
| Dopamine hydrochloride 160mg/mL infusion concentrate 5mL ampule |
Product containing precisely dopamine hydrochloride 160 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dopamine hydrochloride 40mg/mL infusion concentrate 5mL ampule |
Dopamine hydrochloride 40 mg/mL solution for injection |
| Dopexamine hydrochloride 10mg/mL infusion concentrate 5mL ampule |
Product containing precisely dopexamine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Dornase alfa 2500units(2.5mg) nebulizer solution |
Dornase alfa 1 mg/mL solution for nebuliser |
| Dorsal finger flap |
Flap (substance) |
| Dorsal metatarsal fasciocutaneous flap |
Dorsal metatarsal artery fasciocutaneous flap |
| Dorsal thumb flap |
Flap (substance) |
| Dorsal tongue flap |
Flap (substance) |
| Dorsalis pedis flap |
Dorsalis pedis artery flap |
| Dorsolateral sulcus |
Medulla oblongata dorsal lateral sulcus |
| Dose form by site prepared for |
Pharmaceutical dose form (dose form) |
| Dothiepin hydrochloride 25mg/5mL conventional release oral elixir |
Dosulepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 25mg/5mL s/f elixir |
Dosulepin 5 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL conventional release oral elixir |
Dosulepin 15 mg/mL oral solution |
| Dothiepin hydrochloride 75mg/5mL s/f elixir |
Dosulepin 15 mg/mL oral solution |
| Double - DT - vaccination (& [pre-school] ) |
Preschool administration of diphtheria and tetanus vaccine |
| Double - DT - vaccination |
Preschool administration of diphtheria and tetanus vaccine |
| Double pedicle flap graft |
Reconstruction using bipedicled flap |
| Down's incontinence apparatus |
Incontinence appliance (physical object) |
| Doxazosin mesylate 8mg tablet |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
| Doxepin hydrochloride 10mg/mL oral solution |
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Doxepin metabolite |
Product containing doxepin (medicinal product) |
| Doxorubicin hydrochloride 10mg injection solution vial |
Doxorubicin hydrochloride 10 mg powder for solution for injection vial |
| Doxorubicin hydrochloride 20mg injection solution vial |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxorubicin liposomal 20mg/10ml injection |
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Doxycycline 100mg dispersible tablet |
Doxycycline 100 mg orodispersible tablet |
| Doxycycline 40mg m/r capsule |
Product containing precisely doxycycline 40 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Doxycycline 75mg orally disintegrating tablet |
Doxycycline anhydrous (as doxycycline) 75 mg orodispersible tablet |
| Doxycycline calcium 50mg/5mL syrup |
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Doxycycline hyclate 10% subgingival delivery system |
Product containing only doxycycline in oromucosal dose form (medicinal product form) |
| Doxycycline hyclate 200mg injection (pdr for recon) |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline hyclate 200mg powder for injection solution vial |
Product containing only doxycycline in parenteral dose form (medicinal product form) |
| Doxycycline monohydrate 25mg/5mL suspension |
Doxycycline anhydrous (as doxycycline) 5 mg/mL oral suspension |
| Drain insertion - action |
Insertion - action (qualifier value) |
| Drainage bleb, functional |
Functional filtering bleb (finding) |
| Drainage of boil of skin NEC |
Drainage of boil of skin |
| Drainage of cyst NEC |
Drainage procedure |
| Drainage of cyst of pancreas into jejunum NEC |
Pancreaticocystojejunostomy |
| Drainage of female perineal abscess |
Drainage of perineal abscess (procedure) |
| Drainage of male periurethral abscess |
Drainage of periurethral abscess (procedure) |
| Drainage of organ NOC |
Drainage procedure |
| Drainage of organ NOC NOS |
Drainage procedure |
| Drechslera longirostrata |
Exserohilum longirostratum |
| Dressing - action |
Application - action |
| Dried factor IX fraction heated 600iu powder and solvent for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
| Dried factor IX fraction heated 600iu powder for conventional release solution for injection solution vial |
Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
| Drilling of organ NOC |
Drilling |
| Drimaren brilliant yellow |
Textile colours and finishes patch test substance |
| Drop attacks in middle-aged woman |
Drop attack |
| Drostanolone propionate allergy |
Allergy to drostanolone (finding) |
| Drotrecogin alfa (activated) 5mg powder for infusion solution vial |
Drotrecogin alfa 5 mg powder for solution for injection vial |
| Drotrecogin alfa 20mg powder for infusion solution vial |
Product containing precisely drotrecogin alfa 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Drug |
Pharmaceutical / biologic product (product) |
| Drug aerosol, 0,01% |
Drug aerosol |
| Drug aerosol, 0,04% |
Drug aerosol |
| Drug aerosol, 0,5% |
Drug aerosol |
| Drug cream, 0,01% |
Cream |
| Drug cream, 0,02% |
Cream |
| Drug cream, 0,025% |
Cream |
| Drug cream, 0,05% |
Cream |
| Drug cream, 0,1% |
Cream |
| Drug cream, 0,25% |
Cream |
| Drug cream, 0,5% |
Cream |
| Drug cream, 1% |
Cream |
| Drug cream, 2,5% |
Cream |
| Drug dependence |
Substance dependence (disorder) |
| Drug dependence - unspecified whether during pregnancy or the puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
| Drug dependence NOS |
Substance dependence (disorder) |
| Drug dependence NOS |
Substance dependence (disorder) |
| Drug dependence during childbirth, puerperium (& pregnancy) |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
| Drug dependence during pregnancy, childbirth and the puerperium |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
| Drug dependence during pregnancy, childbirth or the puerperium NOS |
Substance dependence during pregnancy, childbirth and/or puerperium (disorder) |
| Drug dependence in childbirth |
Substance dependence in childbirth |
| Drug dependence in mother complicating pregnancy, childbirth AND/OR puerperium |
Substance dependence in mother complicating pregnancy, childbirth and/or puerperium (disorder) |
| Drug dependence in remission |
Substance dependence in remission |
| Drug dependence, continuous |
Substance dependence, continuous |
| Drug dependence, episodic |
Substance dependence, episodic (disorder) |
| Drug gel, 0,05% |
Gel |
| Drug gel, 0,1% |
Gel |
| Drug gel, 0,25% |
Gel |
| Drug groups and agents primarily acting on skin adverse reaction |
Adverse reaction to drug |
| Drug groups primarily affecting autonomic nervous system adverse reaction |
Adverse reaction to drug |
FHIR